Richard A. Barasch - 17 Jun 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Reporting relationship: Director
Issuer ticker: TOI
Reported as of: 17 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jun 2025, 20:59:24 UTC
Prior SEC filing: 28 Mar 2025
Next SEC filing: 28 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch

Key filing fact

Richard A. Barasch filed Form 4 for Oncology Institute, Inc. (TOI) on 20 Jun 2025.

Key facts

This page summarizes Richard A. Barasch's Form 4 filing for Oncology Institute, Inc. (TOI).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Jun 2025, 20:59.

Change

Previous filing in this sequence was filed on 28 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001076341 Primary reporting owner

BARASCH RICHARD A

Relationship: Director
Address: C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch
Signature date: 20 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +159,500
Change %: +9%
Price: $0.000000
Shares after: 1,935,141
Date: 17 Jun 2025
Ownership: Direct
Footnotes: F1, F2

TOI transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +620,400
Change %: +32%
Price: $0.000000
Shares after: 2,555,541
Date: 18 Jun 2025
Ownership: By Trust
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TOI transaction Derivative

Class A Common Equivalent Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -1,595
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 159,500
Exercise price: $0.000000
Footnotes: F1, F2, F4

TOI transaction Derivative

Class A Common Equivalent Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -6,204
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 18 Jun 2025
Ownership: By Trust
Underlying class: Common Stock
Underlying amount: 620,400
Exercise price: $0.000000
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the "Preferred Stock") into shares of the Issuer's common stock, par value $0.0001 (the "Common Stock") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the "Certificate of Designation").

Footnote F2

Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion.

Footnote F3

Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.

Footnote F4

Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date.